BLANCA
GUTIÉRREZ MARTÍNEZ
CATEDRÁTICA DE UNIVERSIDAD
Universitat de Barcelona
Barcelona, EspañaUniversitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (37)
2023
2022
-
Completed suicide is associated with a higher polygenic burden for psychiatric disorders
European Archives of Psychiatry and Clinical Neuroscience
-
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Nature, Vol. 604, Núm. 7906, pp. 502-508
-
Toxoplasma gondii Seropositivity Interacts with Catechol-O-methyltransferase Val105/158Met Variation Increasing the Risk of Schizophrenia
Genes, Vol. 13, Núm. 6
2019
-
A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments
Translational Psychiatry, Vol. 9, Núm. 1
2014
-
Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain
Schizophrenia Research, Vol. 159, Núm. 1, pp. 107-113
2007
-
Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment
Journal of Affective Disorders, Vol. 104, Núm. 1-3, pp. 83-90
-
Identification of two risk haplotypes for schizophrenia and bipolar disorder in the synaptic vesicle monoamine transporter gene (SVMT)
American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 144, Núm. 4, pp. 502-507
2005
-
Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram
Journal of Psychopharmacology, Vol. 19, Núm. 2, pp. 166-172
2004
-
Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders
Psychiatric Genetics, Vol. 14, Núm. 4, pp. 203-208
-
Dermatoglyphic profile in 22q Deletion syndrome
American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 128 B, Núm. 1, pp. 46-49
-
Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder
Journal of Medical Genetics, Vol. 41, Núm. 3, pp. 219-223
2003
-
5-HTTLPR Polymorphism of the Serotonin Transporter Gene Predicts Non-Remission in Major Depression Patients Treated with Citalopram in a 12-Weeks Follow Up Study
Journal of Clinical Psychopharmacology, Vol. 23, Núm. 6, pp. 563-567
2002
-
Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT1A receptor gene as putative risk factors in major depression [3]
Molecular Psychiatry
-
Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response
Schizophrenia Research, Vol. 58, Núm. 1, pp. 93-97
2001
-
Association study between novel promoter variants at the 5-HT2C receptor gene and human patients with bipolar affective disorder
Neuroscience Letters, Vol. 309, Núm. 2, pp. 135-137
-
Dermatoglyphics and abnormal palmar flexion creases as markers of early prenatal stress in children with idiopathic intellectual disability
Journal of Intellectual Disability Research, Vol. 45, Núm. 5, pp. 416-423
-
Genetic variation in the 5-HT5A receptor gene in patients with bipolar disorder and major depression
Neuroscience Letters, Vol. 303, Núm. 2, pp. 111-114
-
The 5-HT2A receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients
American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 105, Núm. 8, pp. 801-804
-
Variability in the 5-HT2A receptor gene is associated with seasonal pattern in major depression
Molecular Psychiatry, Vol. 6, Núm. 2, pp. 239-242